Evidence map›Paper›PMID 40385452›Full record

ArticlemedRxiv : the preprint server for health sciences2025

The effect of type 2 diabetes genetic predisposition on non-cardiovascular comorbidities.

Ana Luiza Arruda, Ozvan Bocher, Henry J Taylor, Davis Cammann, Satoshi Yoshiji, Xianyong Yin, Chi Zhao, Jingchun Chen, Alexis C Wood, Ken Suzuki and 9 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Ana Luiza ArrudaInstitute of Translational Genomics, Helmholtz Munich, Neuherberg, 85764, Germany.
Ozvan BocherInstitute of Translational Genomics, Helmholtz Munich, Neuherberg, 85764, Germany.ORCID 0000-0002-2467-9236
Henry J TaylorCenter for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Davis CammannNevada Institute of Personalized Medicine, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.
Satoshi YoshijiPrograms in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Xianyong YinDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
Chi ZhaoDepartment of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA.
Jingchun ChenNevada Institute of Personalized Medicine, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Las Vegas, NV 89154, USA.ORCID 0000-0001-9408-0117
Alexis C WoodUSDA/ARS Children's Nutrition Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-7616-2119
Ken SuzukiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Josep M MercaderPrograms in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0001-8494-3660
Cassandra N SpracklenDepartment of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA.ORCID 0000-0003-3590-7182
James B MeigsPrograms in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Marijana VujkovicCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.ORCID 0000-0003-4924-5714
George Davey SmithMRC Integrative Epidemiology Unit, University of Bristol, BS8 2BN Bristol, UK.
Jerome I RotterInstitute for Translational Genomics and Population Sciences, Department of Pediatrics, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Benjamin F VoightCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.ORCID 0000-0002-6205-9994
Andrew P MorrisCentre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom.
Eleftheria ZegginiInstitute of Translational Genomics, Helmholtz Munich, Neuherberg, 85764, Germany.

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALAN R. SALTIEL · 2003 to 2026
$40.4M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Multiple AncestriesU01HG011723 · NHGRI · BROAD INSTITUTE, INC. · PI Alisa Knodle Manning, Josep Maria Mercader · 2021 to 2026
$5.7M
GEneration and assessment of Multi-omic informed Subtypes of Type 2 Diabetes in Diverse Populations (GEMS-T2D)U01DK140757 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Josep Maria Mercader, KRISTINA Marie UTZSCHNEIDER · 2024 to 2026
$2.3M
Cataloging multi-ancestry 'omic readouts of the environmental and genetic determinants of type 2 diabetesR01DK137993 · NIDDK · HARVARD MEDICAL SCHOOL · PI ARJUN KUMAR MANRAI, Josep Maria Mercader · 2024 to 2026
$2.0M
Convolutional Neural Network for Disease Prediction, Biomarker Discovery, and Validation in Alzheimer's DiseaseR15AG083618 · NIA · UNIVERSITY OF NEVADA LAS VEGAS · PI Jingchun Chen · 2024 to 2026
$751k
NCATS NIH HHS UL1 TR001881NHGRI NIH HHS U01 HG011723NHLBI NIH HHS R01 HL105756NIA NIH HHS R15 AG083618NIDDK NIH HHS L30 DK106874NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK137993NIDDK NIH HHS U01 DK140757
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is epidemiologically associated with a wide range of non-cardiovascular comorbidities, yet their shared etiology has not been fully elucidated. Leveraging eight non-overlapping mechanistic clusters of T2D genetic profiles, each representing distinct biological pathways, we investigate putative causal links between cluster-stratified T2D genetic predisposition and 21 non-cardiovascular comorbidities. Most of the identified putative causal effects are driven by distinct T2D genetic clusters. For example, the risk-increasing effects of T2D genetic predisposition on cataracts and erectile dysfunction are primarily attributed to obesity and glucose regulation mechanisms, respectively. When surveyed in populations across the globe, we observe opposing effect directions for depression, asthma and chronic obstructive pulmonary disease between populations. We identify a putative causal link between T2D genetic predisposition and osteoarthritis. To underscore the translational potential of our findings, we intersect high-confidence effector genes for osteoarthritis with targets of T2D-approved drugs and identify metformin as a potential candidate for drug repurposing in osteoarthritis.

Identifiers

PMID40385452
PMCPMC12083600

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.